Search by Drug Name or NDC
NDC 44567-0246-85 Cefoxitin 2 g/1 Details
Cefoxitin 2 g/1
Cefoxitin is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by WG Critical Care, LLC. The primary component is CEFOXITIN SODIUM.
MedlinePlus Drug Summary
Cefoxitin injection is used to treat infections caused by bacteria including pneumonia and other lower respiratory tract (lung) infections; and urinary tract, abdominal (stomach area), female reproductive organs, blood, bone, joint, and skin infections. Cefoxitin injection may also be used before and during surgery, in order to prevent the patient from getting an infection. Cefoxitin injection is in a class of medications called cephamycin antibiotics. It works by killing bacteria. Antibiotics such as cefoxitin injection will not work for colds, flu, or other viral infections. Taking antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 44567-0246-85Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cefoxitin Injection
Product Information
| NDC | 44567-0246 |
|---|---|
| Product ID | 44567-246_fa6d5377-af57-45a8-aa38-685877c809a7 |
| Associated GPIs | 02200060102110 |
| GCN Sequence Number | 015945 |
| GCN Sequence Number Description | cefoxitin sodium VIAL 2 G INTRAVEN |
| HIC3 | W1X |
| HIC3 Description | CEPHALOSPORIN ANTIBIOTICS - 2ND GENERATION |
| GCN | 33942 |
| HICL Sequence Number | 003979 |
| HICL Sequence Number Description | CEFOXITIN SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Cefoxitin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cefoxitin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | g/1 |
| Substance Name | CEFOXITIN SODIUM |
| Labeler Name | WG Critical Care, LLC |
| Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065414 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 44567-0246-85 (44567024685)
| NDC Package Code | 44567-246-85 |
|---|---|
| Billing NDC | 44567024685 |
| Package | 25 VIAL in 1 CARTON (44567-246-85) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Marketing Start Date | 2017-07-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |